- Home
- SVT vs RNLX Comparison
SVT vs RNLX Comparison
Compare SVT & RNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVT
- RNLX
- Stock Information
- Founded
- SVT 1959
- RNLX 2018
- Country
- SVT United States
- RNLX United States
- Employees
- SVT N/A
- RNLX N/A
- Industry
- SVT Industrial Machinery/Components
- RNLX Medical Specialities
- Sector
- SVT Consumer Discretionary
- RNLX Health Care
- Exchange
- SVT Nasdaq
- RNLX Nasdaq
- Market Cap
- SVT 31.3M
- RNLX 26.1M
- IPO Year
- SVT N/A
- RNLX 2020
- Fundamental
- Price
- SVT $11.74
- RNLX $0.29
- Analyst Decision
- SVT
- RNLX Strong Buy
- Analyst Count
- SVT 0
- RNLX 1
- Target Price
- SVT N/A
- RNLX $3.00
- AVG Volume (30 Days)
- SVT 8.9K
- RNLX 1.1M
- Earning Date
- SVT 11-07-2024
- RNLX 11-12-2024
- Dividend Yield
- SVT N/A
- RNLX N/A
- EPS Growth
- SVT N/A
- RNLX N/A
- EPS
- SVT 0.17
- RNLX N/A
- Revenue
- SVT $46,639,000.00
- RNLX $2,221,000.00
- Revenue This Year
- SVT N/A
- RNLX $48.40
- Revenue Next Year
- SVT N/A
- RNLX $104.00
- P/E Ratio
- SVT $39.25
- RNLX N/A
- Revenue Growth
- SVT 26.13
- RNLX N/A
- 52 Week Low
- SVT $8.80
- RNLX $0.22
- 52 Week High
- SVT $14.10
- RNLX $2.40
- Technical
- Relative Strength Index (RSI)
- SVT 46.28
- RNLX 44.88
- Support Level
- SVT $11.20
- RNLX $0.27
- Resistance Level
- SVT $13.01
- RNLX $0.31
- Average True Range (ATR)
- SVT 0.53
- RNLX 0.03
- MACD
- SVT -0.12
- RNLX -0.00
- Stochastic Oscillator
- SVT 12.15
- RNLX 45.83
About SVT Servotronics Inc.
Servotronics Inc is a U.S based company that designs, manufactures, and markets servo valves, including torque motor, hydraulic, and pneumatic valves. The company has single reportable segment which is aerospace Its products are marketed and sold throughout the United States and in select foreign markets. These products are sold to commercial aviation manufacturers, government prime contractors, government subcontractors, and end-users.
About RNLX Renalytix plc
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally. The company's product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.